These shale explorers have been leading the market of late, and have much more upside given rapid production gains and fast-growing reserves. Read More
Archive
Filter
The rapid expansion of America’s health care bureaucracy is the right Rx for these four stocks. Read More
Rising global demand for food combined with supply constraints will benefit these agriculture sector investments. Read More
The first quarter’s economic weakness surprisingly was not attributed primarily to poor weather in the US. Instead, a sharp 7.6 percent drop in exports, partly because of economic weakness in Europe and Asia, received most of the blame. Read More
Not too hot, not too cold. Read More
Market share and cost efficiencies are the goals. Read More
PF Growth Portfolio recommendation Allergan NYSE: AGN) is the target of an unsolicited take over offer announced late Monday, April 21. The suitor is another portfolio member, Valeant Pharmaceuticals International (NYSE: VRX), which has teamed up with activist investor William Ackman.If successful, the deal would create a global giant in… Read More
You can survive the financial consequences of divorce. Read More
These funds are great plays on the shale revolution in North America. Read More